| Eosinophils from physiology to disease: a comprehensive review GA Ramirez, MR Yacoub, M Ripa, D Mannina, A Cariddi, N Saporiti, ... BioMed research international 2018, 2018 | 288 | 2018 |
| Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation R Greco, F Lorentino, M Morelli, F Giglio, D Mannina, A Assanelli, ... Blood, The Journal of the American Society of Hematology 128 (11), 1528-1531, 2016 | 56 | 2016 |
| Real-world validation of molecular international prognostic scoring system for myelodysplastic syndromes E Sauta, M Robin, M Bersanelli, E Travaglino, M Meggendorfer, LP Zhao, ... Journal of Clinical Oncology 41 (15), 2827-2842, 2023 | 48 | 2023 |
| Human herpesvirus 6 infection following haploidentical transplantation: immune recovery and outcome R Greco, L Crucitti, M Noviello, S Racca, D Mannina, A Forcina, ... Biology of Blood and Marrow Transplantation 22 (12), 2250-2255, 2016 | 38 | 2016 |
| Janus kinase inhibition for graft-versus-host disease: current status and future prospects D Mannina, N Kröger Drugs 79, 1499-1509, 2019 | 27 | 2019 |
| Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies R Duléry, C Goudet, D Mannina, A Bianchessi, A Granata, S Harbi, ... Bone Marrow Transplantation 58 (4), 386-392, 2023 | 19 | 2023 |
| Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with … L Castagna, V Valli, I Timofeeva, R Capizzuto, S Bramanti, J Mariotti, ... Transplantation and Cellular Therapy 27 (6), 478. e1-478. e5, 2021 | 15 | 2021 |
| Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation D Mannina, N Gagelmann, A Badbaran, M Ditschkowski, R Bogdanov, ... European Journal of Haematology 103 (6), 552-557, 2019 | 12 | 2019 |
| Risk factors for early cytomegalovirus reactivation and impact of early cytomegalovirus reactivation on clinical outcomes after T cell-replete haploidentical transplantation … J Mariotti, F Legrand, S Furst, L Giordano, F Magri, L Richiardi, A Granata, ... Transplantation and cellular therapy 28 (3), 169. e1-169. e9, 2022 | 8 | 2022 |
| Major central nervous system complications after allogeneic stem cell transplantation: A large retrospective study on 888 consecutive adult patients D Mannina, L Berneking, A Both, W Timm, T Urbanowicz, C Wolschke, ... European Journal of Haematology 105 (6), 722-730, 2020 | 8 | 2020 |
| Reduced intensity allogeneic stem cell transplantation for younger patients with myelofibrosis D Mannina, T Zabelina, C Wolschke, M Heinzelmann, I Triviai, ... British Journal of Haematology 186 (3), 484-489, 2019 | 8 | 2019 |
| Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients M Noviello, F Lorentino, E Xue, S Racca, G Furnari, V Valtolina, ... Blood Advances 7 (18), 5446-5457, 2023 | 7 | 2023 |
| Nonmyeloablative conditioning regimen including low-dose total marrow/lymphoid irradiation before haploidentical transplantation with post-transplantation cyclophosphamide in … B Sarina, P Mancosu, P Navarria, S Bramanti, J Mariotti, C De Philippis, ... Transplantation and Cellular Therapy 27 (6), 492. e1-492. e6, 2021 | 7 | 2021 |
| EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide J Mariotti, F Magri, L Giordano, C De Philippis, B Sarina, D Mannina, ... Bone Marrow Transplantation 58 (3), 247-256, 2023 | 6 | 2023 |
| Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis D Mannina, A Badbaran, C Wolschke, E Klyuchnikov, M Christopeit, ... Bone Marrow Transplantation 57 (3), 510-512, 2022 | 6 | 2022 |
| Impact of Preemptive Use of Tocilizumab on Chimeric Antigen Receptor T Cell Outcomes in Non-Hodgkin Lymphoma C De Philippis, D Mannina, L Giordano, E Costantini, S Marcheselli, ... Transplantation and Cellular Therapy 29 (7), 429. e1-429. e6, 2023 | 3 | 2023 |
| Real-World validation of molecular international prognostic scoring system (IPSS-M) for myelodysplastic syndromes E Sauta, M Robin, M Bersanelli, E Travaglino, M Meggendorfer, LP Zhao, ... Blood 140 (Supplement 1), 1121-1124, 2022 | 3 | 2022 |
| Feasibility and efficacy of a pharmacokinetics-guided busulfan conditioning regimen for allogeneic stem cell transplantation with post-transplantation cyclophosphamide as graft … S Bramanti, C De Philippis, A Bartoli, L Giordano, J Mariotti, B Sarina, ... Transplantation and Cellular Therapy 27 (11), 912. e1-912. e6, 2021 | 3 | 2021 |
| Ibrutinib compared to standard chemotherapy for central nervous system recurrence of mantle cell lymphoma C Rusconi, D Tucker, S Bernard, C Muzi, L Crucitti, P Stefani, M Cox, ... Hematol Oncol 37, 244-5, 2019 | 3 | 2019 |
| Nanosphere’s Verigene® blood culture assay to detect multidrug-resistant Gram-negative bacterial outbreak: a prospective study on 79 hematological patients in a country with … R Greco, MC Barbanti, N Mancini, L Infurnari, R Pasciuta, A Forcina, ... Clinical Hematology International 1 (2), 120-123, 2019 | 3 | 2019 |
